Top compounds associated with response to LYZL6


Feature Type Standardized
Nominal ANOVA
mRNA lenalidomide GDSC1000 pan-cancer AAC -0.071 0.05
mRNA phenformin GDSC1000 pan-cancer AAC 0.061 0.05
mRNA BRD-A05715709 CTRPv2 pan-cancer AAC -0.11 0.05
mRNA BHG712 GDSC1000 pan-cancer AAC 0.058 0.05
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.07 0.05
mRNA SR-II-138A CTRPv2 pan-cancer AAC -0.062 0.05
mRNA RAF265 CTRPv2 pan-cancer AAC -0.079 0.05
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.05
mRNA FQI-2 CTRPv2 pan-cancer AAC -0.062 0.05
mRNA XMD14-99 GDSC1000 pan-cancer AAC 0.063 0.05
Download CSV